Blog - Page 2981 of 5589

WednesdayFeb 20, 2013 7:49 am

Viscount Systems, Inc. (VSYS) Acquires Contract to Secure Facility for International Manufacturer

Viscount Systems, a leading-edge supplier of security systems and software, this morning announced that it has received an initial order for its Freedom access control solution from an international manufacturer and supplier of industrial solutions. According to the press release, this contract could potentially lead to securing a total of 65 facilities owned or managed by this client. The systems to be installed will include Freedom access control running on Viscount’s patent-pending Microsoft Active Directory platform. Microsoft’s virtualization platform that makes it easier for businesses to virtualize existing server hardware assets and move them to the cloud. “This project demonstrates…

TuesdayFeb 19, 2013 2:27 pm

Viscount Systems, Inc. (VSYS) Thinks It’s Time for a Change

Viscount Systems designs, manufactures, and services a range of access control and security products for clients around the world. The company focuses on door access control, emergency communications, and other security systems and components currently installed in approximately 35,000 sites in over 30 countries, including prisons, schools, hospitals, and corporate offices. They’ve been in the industry since 1969, but today they’re one of the few that have positioned themselves for major security changes that are long overdue. Access control, a $10 billion part of the $100 billion security market, has been dominated by multi-national corporations, such as Honeywell and UTC.…

TuesdayFeb 19, 2013 10:39 am

Savient Pharmaceuticals, Inc. (SVNT) and Sobi Announce Agreement to Co-Promote Kineret in the US

Savient Pharmaceuticals is a specialty biopharmaceutical company whose mission is to develop and commercialize pharmaceutical specialty products. The company announced today that it and Swedish Orphan Biovitrum AB (SOBI) have entered into an agreement for the co-promotion of Kineret (anakinra) in the United States. Sobi, an international specialty healthcare company dedicated to treatments for rare diseases, has a product portfolio primarily focused on inflammation and genetic diseases, with three late-stage biological development projects. Additionally, the company markets a portfolio of specialty and rare products with overseas partners such as Savient. Kineret, a recombinant IL-1 receptor antagonist, is a treatment for…

FridayFeb 15, 2013 2:36 pm

GlobalWise Investments, Inc. (GWIV) and the World Computer

Cloud technology, in its many and varied manifestations, is becoming as big a revolution for the Internet as the Internet itself has been for business and personal communication. Computers by themselves allow us to store and process tremendous amounts of information on a local basis. The Internet has allowed us to link the world’s computers, effectively replacing the information on our local computer with virtually unlimited information through the global computer network. Today, cloud technology is pursuing the next logical step, allowing us to capture and utilize not just information but processing functionality from all over the world. In effect,…

FridayFeb 15, 2013 2:35 pm

Northwest BioTherapeutics, Inc. (NWBO) Advances Toward Commencement of Phase III Brain Cancer Trial in Europe

Today, Northwest Biotherapeutics announced that it has named a leading international contract research organization (CRO) to manage its 312-patient Phase III clinical trial for Glioblastoma multiforme (GBM) brain cancer in Europe – building on almost three years of manufacturing development, regulatory processes, and clinical preparations there. Well underway in the United States, NW Bio’s Phase III trial is currently enrolling at 41 sites. The U.S. trial is being managed by a U.S. CRO that does not have operations in Europe that can accommodate this trial. Having undergone considerable preparations and regulatory approvals in Europe, the trial is poised to begin…

FridayFeb 15, 2013 2:34 pm

Rafarma Pharmaceuticals, Inc. (RAFA) is “One to Watch”

Rafarma Pharmaceuticals, Inc. is a multiproduct pharmaceutical company specializing in the production of generic antibiotics and specialty pharmaceuticals, including its own proprietary products approved by the ministry of health. Rafarma stands as one of the most ambitious projects in recent medical history, having constructed the most technologically advanced pharmaceutical plant in Russia. Based in Terbuny, Lipetsk region, Russia, Rafarma possesses a unique niche in the burgeoning pharmaceutical market and is poised to become a major player in the international drug industry. The company was established under the auspices of the Foundation to Support Health Care and has been approved by…

FridayFeb 15, 2013 10:54 am

Liberator Medical Holdings, Inc. (LBMH) Reports First Quarter Revenue of $17.6 Million

The subsidiary of Liberator Medical Holdings, Liberator Medical Supply, established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible senior citizens. The company offers a simple, reliable way to buy medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance companies. The company yesterday announced the financial results for its first fiscal quarter ended December 31, 2012. Sales increased by $2.755 million, or 18.6%, to $17.551 million, versus sales of $14.796 million in the same year ago period. The increased sales were due to…

FridayFeb 15, 2013 10:53 am

TechPrecision Corp. (TPCS) Subsidiary Ships First AOS-100A Isotope Transport Cask to Alpha-Omega Commercial Company

TechPrecision, a global manufacturer of large-scale, metal fabricated, and machined precision components, today said its subsidiary, Ranor, has shipped the first AOS-100A Isotope Transport Cask to a commercial customer of Alpha-Omega Services Inc., reflecting a long-standing collaboration. The units were approved by the Nuclear Regulatory Commission (NRC), as Ranor has passed the NRC manufacturing process and quality audit for the cask production in March of 2012. “This shipment marks a milestone for TechPrecision’s Ranor subsidiary, for Alpha-Omega Services, and for the nuclear industry,” James Molinaro, CEO of TechPrecision stated in the press release. “This isotope transport cask enables safe transport…

FridayFeb 15, 2013 7:45 am

International Stem Cell Corp. (ISCO) Fortifies Portfolio of Intellectual Property

International Stem Cell Corp., a California-based biotechnology company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs), just announced that amendments have been made to its license agreements with Advanced Cell Technology, Inc. First entered into in 2004, the license agreements provide access to an array of patents and patent applications for the use of various technologies in certain human tissues. Through these amendments, ISCO has extended its existing rights in the area of parthenogenesis, as well as the therapeutic use of parthenogenetically derived stem cells for treating any human diseases. ISCO now has an exclusive worldwide license…

FridayFeb 15, 2013 7:45 am

Neogenomics, Inc. (NEO) Video Chart for Friday, February 15, 2013

NEO made a push on Thursday with volume increasing significantly over the prior days. At this point the chart is testing top-end resistance levels at $3.10 as it looks to breakout to new 52-week highs and continue a long-term uptrend. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

Site Search

Company Search